The recognition, physiology, and treatment of medication-induced methemoglobinemia

a case report.

Michael D. Turner, Vasiliki Karlis, Robert Glickman

Research output: Contribution to journalArticle

Abstract

Dapsone is a leprostatic agent commonly prescribed for the management of leprosy, malaria, and the immunosuppression-induced infections of Pneumocystis carinii and Toxoplasma gondii. In susceptible patients, methemoglobinemia, a potentially life-threatening event, can occur. We report a case of dapsone-induced methemoglobinemia which was observed during general anesthesia for the management of a fractured mandible. The pathophysiology, diagnosis, and management of dapsone-induced methemoglobinemia will be discussed.

Original languageEnglish (US)
Pages (from-to)115-117
Number of pages3
JournalAnesthesia Progress
Volume54
Issue number3
DOIs
StatePublished - Sep 2007

Fingerprint

Methemoglobinemia
Dapsone
Leprostatic Agents
Pneumocystis Infections
Toxoplasma
Leprosy
Mandible
Immunosuppression
General Anesthesia
Malaria
Therapeutics

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The recognition, physiology, and treatment of medication-induced methemoglobinemia : a case report. / Turner, Michael D.; Karlis, Vasiliki; Glickman, Robert.

In: Anesthesia Progress, Vol. 54, No. 3, 09.2007, p. 115-117.

Research output: Contribution to journalArticle

@article{1f78aba9b03d4a23be2740cbe7a60fb4,
title = "The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report.",
abstract = "Dapsone is a leprostatic agent commonly prescribed for the management of leprosy, malaria, and the immunosuppression-induced infections of Pneumocystis carinii and Toxoplasma gondii. In susceptible patients, methemoglobinemia, a potentially life-threatening event, can occur. We report a case of dapsone-induced methemoglobinemia which was observed during general anesthesia for the management of a fractured mandible. The pathophysiology, diagnosis, and management of dapsone-induced methemoglobinemia will be discussed.",
author = "Turner, {Michael D.} and Vasiliki Karlis and Robert Glickman",
year = "2007",
month = "9",
doi = "10.2344/0003-3006(2007)54[115:TRPATO]2.0.CO;2",
language = "English (US)",
volume = "54",
pages = "115--117",
journal = "Anesthesia Progress",
issn = "0003-3006",
publisher = "Allen Press Inc.",
number = "3",

}

TY - JOUR

T1 - The recognition, physiology, and treatment of medication-induced methemoglobinemia

T2 - a case report.

AU - Turner, Michael D.

AU - Karlis, Vasiliki

AU - Glickman, Robert

PY - 2007/9

Y1 - 2007/9

N2 - Dapsone is a leprostatic agent commonly prescribed for the management of leprosy, malaria, and the immunosuppression-induced infections of Pneumocystis carinii and Toxoplasma gondii. In susceptible patients, methemoglobinemia, a potentially life-threatening event, can occur. We report a case of dapsone-induced methemoglobinemia which was observed during general anesthesia for the management of a fractured mandible. The pathophysiology, diagnosis, and management of dapsone-induced methemoglobinemia will be discussed.

AB - Dapsone is a leprostatic agent commonly prescribed for the management of leprosy, malaria, and the immunosuppression-induced infections of Pneumocystis carinii and Toxoplasma gondii. In susceptible patients, methemoglobinemia, a potentially life-threatening event, can occur. We report a case of dapsone-induced methemoglobinemia which was observed during general anesthesia for the management of a fractured mandible. The pathophysiology, diagnosis, and management of dapsone-induced methemoglobinemia will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=38449105361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449105361&partnerID=8YFLogxK

U2 - 10.2344/0003-3006(2007)54[115:TRPATO]2.0.CO;2

DO - 10.2344/0003-3006(2007)54[115:TRPATO]2.0.CO;2

M3 - Article

VL - 54

SP - 115

EP - 117

JO - Anesthesia Progress

JF - Anesthesia Progress

SN - 0003-3006

IS - 3

ER -